Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
SUNLENCA (lenacapavir) is a twice-yearly injectable prescription medicine used in combination with other HIV-1 medicines to treat adults with hard-to-treat HIV-1 infection who have resistance to many HIV-1 medicines and whose current treatment is failing. It does not cure HIV-1 or AIDS.
Parse Score